Kinetics of heparin administration

Area of Science:

• Pharmacology
• Veterinary Medicine
• Drug Delivery

Background:

• Clinicians often prefer intravenous heparin sodium due to unpredictable absorption from extravascular sites.
• Heparin's efficacy relies on achieving and maintaining therapeutic plasma levels.

Purpose of the Study:

• To compare the pharmacokinetic and pharmacodynamic profiles of heparin sodium administered via intravenous, subcutaneous, and intramuscular routes in dogs.
• To evaluate the reliability of different heparin administration methods for achieving anticoagulation.

Main Methods:

• 34 dogs received radiolabeled heparin sodium (sulfur 35) via intravenous, subcutaneous, or intramuscular injection.
• Anticoagulation status and plasma heparin concentrations were monitored at 30-minute intervals post-injection.
• Dosage and route of administration were key variables in the experimental design.

Main Results:

• Intravenous heparin administration resulted in immediate anticoagulation with a predictable decline in plasma levels.
• Subcutaneous and intramuscular injections led to delayed onset of anticoagulant activity and highly variable plasma heparin concentrations.
• A wide range of patient responses was observed following intermittent subcutaneous or intramuscular administration.

Conclusions:

• Continuous intravenous infusion of heparin sodium offers a more reliable method for achieving consistent therapeutic anticoagulation compared to intermittent extravascular administration.
• Understanding heparin absorption variability is crucial for optimizing anticoagulant therapy in clinical practice.
• The study highlights the importance of administration route in heparin sodium's clinical effectiveness.